SC
WST icon

Sierra Capital’s West Pharmaceutical WST Stock Holding History

Sierra Capital’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-47
Closed -$11K – 558
2022
Q4 		$11K Sell
47
-2
-4% -$474 ﹤0.01% 352
2022
Q3 		$12K Hold
49
– – ﹤0.01% 359
2022
Q2 		$15K Sell
49
-3
-6% -$976 ﹤0.01% 418
2022
Q1 		$21K Buy
52
+41
+373% +$16.1K ﹤0.01% 411
2021
Q4 		$5K Buy
+11
New +$4.74K ﹤0.01% 539

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sierra Capital's WST Position: Q1 2023 in Review

Sierra Capital sold out of West Pharmaceutical (WST) in Q1 2023, closing a stake of 47 shares — an estimated $11K sold.

Sierra Capital first reported a position in WST in Q4 2021 and held it in 5 quarters. The position peaked at $21K in Q1 2022. 695 funds tracked by Wall St. Rank hold WST as of Q1 2023.

  • Sierra Capital reported no remaining West Pharmaceutical position as of Q1 2023 after selling out during the quarter.
  • Sierra Capital sold 47 West Pharmaceutical shares in Q1 2023, an estimated $11K.
  • Sierra Capital first reported a position in West Pharmaceutical in Q4 2021 and held it in 5 quarters.
  • Sierra Capital's West Pharmaceutical position peaked at $21K in Q1 2022.
  • 695 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2023.

Based on Sierra Capital's 13F filing for Q1 2023, filed 1 May 2023.